Indefinite Delivery Contract 36C25723D0003

Award Date 10/31/22
Last Date to Order 10/30/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price Award Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded an indefinite delivery contract to Biomerieux Inc. to supply BIOFIRE REAGENTS in support of VA medical and laboratory programs. The contract carries a potential value of $360,000 and permits orders to be placed through April 2028. A firm fixed price delivery order valued at $64,460.79 was also awarded under this contract. The delivery order requires Biomerieux Inc. to provide...
The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 23 (VISN 23), has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of test kit reagents and associated diagnostic platforms. This single-award BPA, with a total ceiling value of $14,732,632.16, is part of Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA - VHA VISN 12) awarded a $28,472 Blanket Purchase Agreement (BPA) Call contract to Biomerieux Inc. for VIDAS REAGENT CPRR products. The BPA Call has a firm fixed price and a period of performance from October 1, 2023 through July 31, 2024. The place of performance is in Emigration Canyon, Utah. This BPA Call was awarded under an existing BPA to support VA-VHA VISN 12's medical...
The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide reagents and E-test strips. The contract has a ceiling value of $200,000 and a period of performance through September 30, 2025. This is a single-award BPA issued under the VA's Veterans Integrated Service Network 1 (VISN 1) to support the agency's clinical diagnostics and infectious disease testing requirements across its healthcare...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics. The single-award BPA, valued at up to $2,971,499.40, is for the supply of Biomerieux's proprietary reagents, diagnostic equipment, and associated maintenance services to the VA's VISN 17 network. The contract is established under the Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, enabling the VA to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded Biomerieux Inc. multiple blanket purchase agreements and call contracts from April 2023 through September 2024 totalling approximately $215,000. Biomerieux Inc. will provide VIDAS diagnostic testing platforms, reagents, and related services as the prime contractor. Performance will occur at Biomerieux's facility in Emigration Canyon, Utah to support infectious disease testing for...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22) awarded a single-award Blanket Purchase Agreement (BPA) to Biomerieux Inc. for Polymerase Chain Reaction (PCR) diagnostic services. The BPA, valued up to $2,273,824.38, has a base year with two one-year option periods, and will provide PCR testing capabilities to VA healthcare facilities within VISN 22, which covers Southern California and Southern Nevada. Biomerieux Inc., a global leader in in vitro...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award, $549,984.84 Indefinite Delivery Contract to Biomerieux Inc. for the provision of Vitek 2 and Vitek MS microbiology diagnostic testing supplies. The contract has a 5-year period of performance from October 1, 2023 to September 30, 2024. Under this IDC, the VA VISN 23 will issue firm-fixed-price delivery orders to Biomerieux's Emigration Canyon, Utah...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single award indefinite delivery contract to Biomerieux Inc. to provide VIDAS reagents in support of laboratory diagnostic testing services. Over four task order awards from June 2020 through June 2023 valued at a total of approximately $351,717, Biomerieux Inc. delivered the requested reagents on a firm fixed price basis to locations in Utah, North Carolina, and elsewhere within...
The Department of Veterans Affairs Veterans Integrated Service Network 8 (VA-VISN 8) awarded a single-award Blanket Purchase Agreement (BPA) to Biomerieux Inc., Biomerieux, Inc. Division, a global leader in in vitro diagnostics and microbiological testing solutions. The BPA, with a ceiling value of $308,938.00, is for the provision of microbiology cost-per-test services to support the VA-VHA's medical and healthcare programs. This contract was awarded under the Critical Analyzers, Laboratory...
  • 36C25723D0003
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single award indefinite delivery contract to Biomerieux Inc. to supply procalcitonin reagents in support of testing programs within VISN 17. The contract has a potential value of $1,000,000 and a period of performance through October 30, 2027. No set-aside designation was applied to this procurement.

Under the indefinite delivery contract, the agency issued a firm fixed price delivery order to Biomerieux Inc. worth $194,400 for the provision of procalcitonin reagents. The place of performance is located in Emigration Canyon, Utah, and the completion date is October 30, 2023. Procalcitonin is a biomarker used to help determine the severity of bacterial infections versus other conditions that cause elevated inflammatory response. This delivery order and underlying contract aim to ensure the continued availability of procalcitonin test reagents to aid clinicians within VISN 17 in diagnosing and monitoring patients with suspected sepsis or other bacterial infections.

Generated 1/5/24, 2:13 AM